Clozapine use in Dual Diagnosis Patients

@inproceedings{Mrta2015ClozapineUI,
  title={Clozapine use in Dual Diagnosis Patients},
  author={M{\'a}rta and Jorge and L{\'o}pez-{\'A}lvarez and Francisco and G. A Ledesma Rubio},
  year={2015}
}
Background: Dual diagnosis (DD), defined as the co-occurrence of a substance use disorder (SUD) and a severe mental illness (SMI), is associated with several negative outcomes. Typical antipsychotics (TAP) are not of great value for patients with DD as they are associated with poorer responses and can worsen SUD. Atypical antipsychotics (AAP) offer several advantages compared to TAP and in DD patients they have been found to be effective in treating both, psychiatric symptoms and substance use… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 54 REFERENCES

Clozapine and amisulpride in refractory schizophrenia and alcohol dependence.

  • Journal of clinical psychopharmacology
  • 2007
VIEW 2 EXCERPTS
HIGHLY INFLUENTIAL

Clozapine treatment in patients with prior substance abuse.

  • Canadian journal of psychiatry. Revue canadienne de psychiatrie
  • 2003
VIEW 1 EXCERPT
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…